NO995722D0 - Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer - Google Patents

Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Info

Publication number
NO995722D0
NO995722D0 NO995722A NO995722A NO995722D0 NO 995722 D0 NO995722 D0 NO 995722D0 NO 995722 A NO995722 A NO 995722A NO 995722 A NO995722 A NO 995722A NO 995722 D0 NO995722 D0 NO 995722D0
Authority
NO
Norway
Prior art keywords
treatment
autoimmune diseases
derivatives useful
triptolide derivatives
new
Prior art date
Application number
NO995722A
Other languages
English (en)
Other versions
NO995722L (no
Inventor
Michel Jean Jung
Mahinda Wickramaratne
Michael Hepperle
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO995722D0 publication Critical patent/NO995722D0/no
Publication of NO995722L publication Critical patent/NO995722L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995722A 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer NO995722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248997A 1997-05-23 1997-05-23
PCT/US1998/008562 WO1998052933A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
NO995722D0 true NO995722D0 (no) 1999-11-22
NO995722L NO995722L (no) 2000-01-21

Family

ID=25338618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995722A NO995722L (no) 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Country Status (18)

Country Link
EP (1) EP0983256B1 (no)
JP (1) JP2002500647A (no)
KR (1) KR20010012820A (no)
AR (1) AR012737A1 (no)
AT (1) ATE261434T1 (no)
AU (1) AU741209B2 (no)
BR (1) BR9809673A (no)
CA (1) CA2288327A1 (no)
DE (1) DE69822297T2 (no)
ES (1) ES2213279T3 (no)
HK (1) HK1025954A1 (no)
HU (1) HUP0003244A3 (no)
IL (1) IL133089A0 (no)
NO (1) NO995722L (no)
NZ (1) NZ500699A (no)
TW (1) TW462966B (no)
WO (1) WO1998052933A1 (no)
ZA (1) ZA984177B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448795A1 (en) * 2001-03-15 2002-09-26 Pharmagenesis, Inc. Amino acid derivatives of triptolide compounds as immune modulators and anticancer agent
EP2468277A1 (en) 2002-05-31 2012-06-27 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
US7820834B2 (en) 2003-12-24 2010-10-26 Pharmagenesis, Inc. Triptolide 5,6-derivatives as immunomodulators and anticancer agents
CN1917893A (zh) 2004-02-09 2007-02-21 美国泛华医药公司 从雷公藤多苷中分离雷公藤内酯醇化合物的方法
EP1732536B1 (en) 2004-03-02 2012-04-25 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2006044496A2 (en) 2004-10-13 2006-04-27 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
US20120020954A1 (en) 2009-03-30 2012-01-26 Anat Achiron Methods of predicting clinical course and treating multiple sclerosis
WO2012123938A1 (en) 2011-03-17 2012-09-20 Tel Hashomer Medical Research Infrastructure And Services Ltd. Quinolone analogs for treating autoimmune diseases
EP3074391B1 (en) 2013-11-28 2019-07-31 Tel Hashomer Medical Research Infrastructure And Services Ltd. Rna polymerase i inhibitors and uses thereof
CN113768939A (zh) * 2021-09-30 2021-12-10 深圳艾克斯恩生物科技有限公司 雷公藤二醇在制备预防和/或治疗nlrp3炎症小体介导的炎症性疾病药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026265A1 (en) * 1993-05-06 1994-11-24 Pharmagenesis, Inc. 16-hydroxytriptolide composition and method for immunotherapy
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
NZ500699A (en) 2001-08-31
ZA984177B (en) 1998-11-23
WO1998052933A1 (en) 1998-11-26
ES2213279T3 (es) 2004-08-16
NO995722L (no) 2000-01-21
TW462966B (en) 2001-11-11
DE69822297T2 (de) 2004-07-29
DE69822297D1 (de) 2004-04-15
BR9809673A (pt) 2000-07-11
EP0983256A1 (en) 2000-03-08
IL133089A0 (en) 2001-03-19
HUP0003244A3 (en) 2001-09-28
HUP0003244A2 (en) 2001-03-28
AR012737A1 (es) 2000-11-08
AU7363498A (en) 1998-12-11
KR20010012820A (ko) 2001-02-26
JP2002500647A (ja) 2002-01-08
ATE261434T1 (de) 2004-03-15
CA2288327A1 (en) 1998-11-26
AU741209B2 (en) 2001-11-22
EP0983256B1 (en) 2004-03-10
HK1025954A1 (en) 2000-12-01

Similar Documents

Publication Publication Date Title
EE04190B1 (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO995095L (no) Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
FI962141A (fi) Rytmihäiriöitä vastustavat bentsodiatsepiinit
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
NO995723L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO973178D0 (no) Indol-derivater anvendelige ved behandling av osteporose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO995722D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
NO306402B1 (no) 3-arylalkenyl-1,2,4-oksadiazolderivater og deres anvendelse, samt mellomprodukter for oppnaaelse av derivatene
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
DE29619359U1 (de) Doppelkammer-Handdusche
NO985325D0 (no) Anvendelse av substituert azaspiran ved behandling av astma
NO984190D0 (no) Fremgangsmåte for behandling av insomnia
SI0983275T1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
KR970005754U (ko) 도어에 공급되는 왁스의 배출장치
EE200300194A (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application